Home
Maria Teresa Bezem's picture

Maria Teresa Bezem

PhD Candidate
  • E-mailMaria.Bezem@uib.no
  • Visitor Address
    Jonas Lies vei 91
    Room 
    5A121B
  • Postal Address
    Postboks 7804
    5020 Bergen

My Ph.D. project focusses on the functionalization of biodegradable nanoparticles with an enzyme called tyrosine hydroxylase (TH). This enzyme catalyzes the rate-limiting step in the dopamine synthesis. Dopamine is a signaling molecule used by neurons to control digestion, mood and motion.  Parkinson's disease or genetic diseases can lead to lack of TH and dopamine. The ultimate goal of the project is to develop an enzyme replacement therapy using nanoparticles loaded with TH. Nanoparticles can in general be used to deliver drugs to specific tissues in the body at the same that they protect the drug from degradation.

Only in Norwegian:

Talk at the annual business seminar by the Research Council of Norway

http://www.forskningsradet.no/no/Artikkel/Forskningsradets_neringslivsda...

Talk at the career week of the faculty of mathematics and natural sciences, University of Bergen, Norway

http://www.uib.no/matnat/53691/kva-skal-du-bli

BMED325: Cellular biochemistry and nanobiochemistry, lecture about the use of nanoparticles in medical research

FARM301: - part 4: Biochemical Methods, clone and purify protein

MEDON1: First semester in medicine and odontology study programs, labexercices in biochemistry (carbohydrates, amino acids, lipids, enzymes, DNA, titration...) 

Academic article
  • 2018. Stabilization of Human Tyrosine Hydroxylase in Maltodextrin Nanoparticles for Delivery to Neuronal Cells and Tissue. Bioconjugate chemistry. 493-502.
  • 2018. Self-Reporting Photoluminescent Porous Silicon Microparticles for Drug Delivery. ACS Applied Materials & Interfaces. 3200-3209.
  • 2016. Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme. Scientific Reports. 14 pages.
Masters thesis
  • 2016. The efficiency of maltodextrin and porous silicon nanoparticles for the in vitro and in vivo stabilization of tyrosine hydroxylase.
  • 2012. Stabilisation of tyrosine hydroxylase in nanoparticles for enzyme replacement therapy.

More information in national current research information system (CRIStin)

Research groups